Statins in Heart Failure

被引：4

作者：

Deedwania, Prakash C. ^{[1
]}

Javed, Usman ^{[1
]}

机构：

[1] Univ Calif San Francisco, Div Cardiol, Vet Affairs Cent Calif Hlth Care Syst, Fresno, CA 93703 USA

来源：

CARDIOLOGY CLINICS | 2008年 / 26卷 / 04期

关键词：

Statin; Heart failure;

D O I：

10.1016/j.ccl.2008.06.006

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

This article reviews the results from several recent reports describing the safety and efficacy of statin therapy in the setting of heart failure. It additionally discusses the ongoing controversy regarding the lipid paradox and possible mechanisms responsible for potential benefit of statin therapy in heart failure.

引用

页码：573 / +

页数：16

共 67 条

[1]

Anand IS, 2004, CIRCULATION, V110, P556

[2]

Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives [J].

Anderssen, SA ;

Hjelstuen, AK ;

Hjermann, I ;

Bjerkan, K ;

Holme, I .

ATHEROSCLEROSIS, 2005, 178 (02) :387-397

[3]

Inflammatory mediators in chronic heart failure: An overview [J].

Anker, SD ;

von Haehling, S .

HEART, 2004, 90 (04) :464-470

[4]

Statin use and survival in patients with chronic heart failure - results from two observational studies with 5200 patients [J].

Anker, Stefan D. ;

Clark, Andrew L. ;

Winkler, Ralf ;

Zugck, Christian ;

Cicoira, Mariantonietta ;

Ponikowski, Piotr ;

Davos, Constantinos H. ;

Banasiak, Waldemar ;

Zardini, Piero ;

Haass, Markus ;

Senges, Jochen ;

Coats, Andrew J. S. ;

Poole-Wilson, Philip A. ;

Pitt, Bertram .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 112 (02) :234-242

[5]

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393] [J].

Armitage, Jane ;

Collins, Rory ;

Bowman, Louise ;

Parish, Sarah ;

Sleight, Peter ;

Peto, Richard ;

Meade, T. ;

Youngman, L. ;

Buxton, M. ;

de Bono, D. ;

George, C. ;

Fuller, J. ;

Keech, A. ;

Mansfield, A. ;

Pentecost, B. ;

Simpson, D. ;

Warlow, C. ;

McNamara, J. ;

O'Toole, L. ;

Doll, R. ;

Wilhelmsen, L. ;

Fox, K. M. ;

Hill, C. ;

Sandercock, P. .

BMC MEDICINE, 2005, 3 (1)

[6]

Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dl treated with statins versus no lipid-lowering drug [J].

Aronow, WS ;

Ahn, C .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02) :147-+

[7]

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention - The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study [J].

Athyros, VG ;

Papageorgiou, AA ;

Mercouris, BR ;

Athyrou, VV ;

Symeonidis, AN ;

Basayannis, EO ;

Demitriadis, DS ;

Kontopoulos, AG .

CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (04) :220-228

[8]

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].

Bellosta, S ;

Via, D ;

Canavesi, M ;

Pfister, P ;

Fumagalli, R ;

Paoletti, R ;

Bernini, F .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678

[9]

Neutral effect on markers of heart failure, inflammation, endothelial activation and function, and vagal tone after high-dose HMG-CoA reductase inhibition in non-diabetic patients with non-ischemic cardiomyopathy and average low-density lipoprotein level [J].

Bleske, BE ;

Nicklas, JM ;

Bard, RL ;

Brook, RD ;

Gurbel, PA ;

Bliden, KP ;

Rajagopalan, S ;

Pitt, B .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) :338-341

[10]

Braunwald E, 2000, CIRCULATION, V102, P14

← 1 2 3 4 5 6 7 →